Excerpt:
I chose the title to this article based on the old adage of "sh**t or get off the pot" -- my sentiments regarding the ongoing Obagi Medical Products (OMPI) saga that has escalated to its current point after VOCE Capital Management wrote an updated note to Obagi shareholders this past Monday.
VOCE released its first open letter to the company and its shareholders in February of this year, which was critical of Obagi's management on several fronts, many I personally agree with, being a former Obagi shareholder myself. VOCE's main contention with the company was regarding the poison pill that the Board of Directors (BOD) put in place in late 2011, clearly designed to thwart any attempt at a hostile takeover.
Read the entire article on Seeking Alpha at
